Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Aardvark Therapeutics, Inc.

Aardvark Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics to Join Prader-Willi Syndrome Community at the 2025 United in Hope Conference
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics to Present at Upcoming Investor Conferences in May
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics Announces Pricing of Initial Public Offering
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Aardvark Therapeutics Appoints Renowned Biopharma Leaders Roy D. Baynes and Susan E. Graf to its Board of Directors
From Aardvark Therapeutics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS